|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
University of Pittsburgh National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Information provided by: | University of Pittsburgh |
| ClinicalTrials.gov Identifier: | NCT00330629 |
Purpose
We propose to add a treatment preference component to a larger study testing standard behavioral treatment (SBT) for weight loss without specific food group restriction vs standard behavioral treatment with gradual elimination of meat, poultry, and fish [a lacto-ovo-vegetarian (LOV) meal plan]. Eligible respondents will be randomized to one of two conditions: Treatment Preference-Yes/No. Individuals in the Treatment Preference-Yes will be assigned to their choice (SBT or SBT+LOV), those in Treatment Preference-No will be randomized to either SBT or SBT+LOV without regard to their preference.
| Condition | Intervention |
|
Obesity Overweight |
Behavioral: Standard Behavioral Treatment Behavioral: Standard Behavior Treatment plus Lacto-ovo-vegetarian diet |
| MedlinePlus related topics: | Obesity Vegetarian Diet Weight Control |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment |
| Official Title: | Preference and Vegetarian Diet in Weight Loss Treatment |
| Estimated Enrollment: | 195 |
| Study Start Date: | January 2002 |
We propose to add a treatment preference component to a larger study testing standard behavioral treatment (SBT) for weight loss without specific food group restriction vs standard behavioral treatment with gradual elimination of meat, poultry, and fish [a lacto-ovo-vegetarian (LOV) meal plan]. Eligible respondents will be randomized to one of two conditions: Treatment Preference-Yes/No. Individuals in the Treatment Preference-Yes will be assigned to their choice (SBT or SBT+LOV), those in Treatment Preference-No will be randomized to either SBT or SBT+LOV without regard to their preference.
Eligibility
| Ages Eligible for Study: | 18 Years to 55 Years |
| Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, Pennsylvania | |||||
| University of Pittsburgh School of Nursing | |||||
| Pittsburgh, Pennsylvania, United States, 15261 | |||||
| University of Pittsburgh |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Principal Investigator: | Lora E. Burke, PhD, MPH, RN | University of Pittsburgh |
More Information
| Study ID Numbers: | 000674, RO1-DK58631 |
| First Received: | May 26, 2006 |
| Last Updated: | May 26, 2006 |
| ClinicalTrials.gov Identifier: | NCT00330629 |
| Health Authority: | United States: Institutional Review Board |
|
|